Macugen® (pegaptanib sodium): Risk of a serious increase in intraocular pressure due to intravitreal injection of excess volume of Macugen®
2012.10.01
Active substance: pegaptanib sodium
In order to ensure a safe intravitreal administration of Macugen®, the excess volume must be expelled from the pre-filled syringe before use.
Annex 1 pictogram (available in German only)
Annex 2 - SPC (available in German only)
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN